CD86 and coronary artery disorder: Our results showed that the expression levels of CD86, PD-1, and CTLA-4 in the peripheral blood of CAD patients were significantly lower than those of healthy individuals, indicating that the co-stimulatory signal required for activation of γδ T cells in CAD patients may be down-regulated in the chronic inflammation environment which established in the CAD patients.